These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37722267)

  • 1. Fluoroalkoxylated C-3 and C-9 (S)-12-bromostepholidine analogues with D1R antagonist activity.
    Namballa HK; Decker AM; Dorogan M; Gudipally A; Goclon J; Harding WW
    Bioorg Chem; 2023 Dec; 141():106862. PubMed ID: 37722267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Selective Dopamine Receptor Ligands Derived from (-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation.
    Namballa HK; Dorogan M; Gudipally AR; Okafor S; Gadhiya S; Harding WW
    J Med Chem; 2023 Jul; 66(14):10060-10079. PubMed ID: 37421373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling.
    Meade JA; Free RB; Miller NR; Chun LS; Doyle TB; Moritz AE; Conroy JL; Watts VJ; Sibley DR
    Psychopharmacology (Berl); 2015 Mar; 232(5):917-30. PubMed ID: 25231919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Activity Relationship Studies on 6-Chloro-1-phenylbenzazepines Leads to the Identification of a New Dopamine D1 Receptor Antagonist.
    Giri R; Namballa HK; Emogaje V; Harding WW
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D
    Moritz AE; Madaras NS; Rankin ML; Inbody LR; Sibley DR
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.
    Madapa S; Gadhiya S; Kurtzman T; Alberts IL; Ramsey S; Reith M; Harding WW
    Eur J Med Chem; 2017 Jan; 125():255-268. PubMed ID: 27688181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional reversal of (-)-Stepholidine analogues by replacement of benzazepine substructure using the ring-expansion strategy.
    Li W; Zhang L; Xu L; Yuan C; Du P; Chen J; Zhen X; Fu W
    Chem Biol Drug Des; 2016 Oct; 88(4):599-607. PubMed ID: 27232055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors.
    Cho DI; Beom S; Van Tol HH; Caron MG; Kim KM
    Biochem Biophys Res Commun; 2006 Nov; 350(3):634-40. PubMed ID: 17022946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain.
    Xu SX; Yu LP; Han YR; Chen Y; Jin GZ
    Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):104-10. PubMed ID: 2530755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity.
    Gadhiya S; Madapa S; Kurtzman T; Alberts IL; Ramsey S; Pillarsetty NK; Kalidindi T; Harding WW
    Bioorg Med Chem; 2016 May; 24(9):2060-71. PubMed ID: 27032890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2.
    Bono F; Tomasoni Z; Mutti V; Sbrini G; Kumar R; Longhena F; Fiorentini C; Missale C
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insights into the D1R agonist and D2R/D3R antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Li B; Li W; Du P; Yu KQ; Fu W
    J Phys Chem B; 2012 Jul; 116(28):8121-30. PubMed ID: 22702398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of D1R/PKA/mTOR signaling cascade in medial prefrontal cortex underlying the antidepressant effects of l-SPD.
    Zhang B; Guo F; Ma Y; Song Y; Lin R; Shen FY; Jin GZ; Li Y; Liu ZQ
    Sci Rep; 2017 Jun; 7(1):3809. PubMed ID: 28630404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.
    Fuxe K; Guidolin D; Agnati LF; Borroto-Escuela DO
    Expert Opin Ther Targets; 2015 Mar; 19(3):377-98. PubMed ID: 25486101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in studies of l-stepholidine and its analogs: chemistry, pharmacology and clinical implications.
    Mo J; Guo Y; Yang YS; Shen JS; Jin GZ; Zhen X
    Curr Med Chem; 2007; 14(28):2996-3002. PubMed ID: 18220736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction.
    Chu H; Jin G; Friedman E; Zhen X
    Cell Mol Neurobiol; 2008 Jun; 28(4):491-9. PubMed ID: 17710533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on C2'-substituted 1-phenylbenzazepines as dopamine D1 receptor ligands.
    Giri R; Namballa HK; Sarker A; Alberts I; Harding WW
    Bioorg Chem; 2022 Oct; 127():105953. PubMed ID: 35772367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK-3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia.
    Wang JR; Sun PH; Ren ZX; Meltzer HY; Zhen XC
    CNS Neurosci Ther; 2017 Feb; 23(2):174-187. PubMed ID: 27996211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.
    Guitart X; Navarro G; Moreno E; Yano H; Cai NS; Sánchez-Soto M; Kumar-Barodia S; Naidu YT; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Ferré S
    Mol Pharmacol; 2014 Oct; 86(4):417-29. PubMed ID: 25097189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.